Vemuganti Geeta Kashyap, Garg Prashant, Gopinathan Usha, Naduvilath Thomas J, John Rajesh K, Buddi Rajeev, Rao Gullapalli N
Ophthalmic Pathology Centre, L. V. Prasad Eye Institute, Hyderabad, India.
Ophthalmology. 2002 Aug;109(8):1538-46. doi: 10.1016/s0161-6420(02)01088-6.
To evaluate the host and agent factors in the progression of mycotic keratitis through the microbiologic evaluation and histologic study of human corneal buttons obtained at the time of therapeutic keratoplasty.
Retrospective noncomparative consecutive case series.
One hundred sixty-seven corneal buttons from 148 patients of microbiologically diagnosed and treated cases of mycotic keratitis who underwent therapeutic keratoplasty between January 1995 and May 1998.
Therapeutic penetrating keratoplasty, review of microbiologic results, histopathologic and microbiologic evaluation of the corneal buttons of mycotic keratitis
Histologic evaluation of the buttons for morphologic changes, degree and distribution of inflammatory cells, presence or absence of fungal filaments, and their degree and distribution within the corneal buttons.
The diagnosis of fungal infection was made on corneal scrapings in 36 cases; whereas in 131 (78%), the fungus was grown in cultures and identified as Aspergillus in 55 (42%), Fusarium in 42 (32%), unidentified hyaline fungi in 22 (17%), dematiaceous (unidentified) in 4 (3%), and others in 8 (6%). The mean interval between diagnosis and keratoplasty was 19 (+/-40) days. From the keratoplasty specimen, the fungus was identified at histologic examination in 127 of 167 (76%) buttons and grown by culture techniques in 76 of 115 (66%) buttons. The fungal species identified in the corneal button were Fusarium in 30 (39%); Aspergillus in 25 (33%); unidentified hyaline in 19 (25%), and others in 2 (3%). Fungus-positive corneal buttons had early surgery (mean, 15 days) compared with fungus-negative (39 days) corneal buttons (P = 0.0005), with 93% fungus positivity in the buttons removed within 2 weeks and 42% after 2 months. In the fungus-positive buttons, there was an inverse correlation between the degree, distribution of inflammatory cells, and fungal filaments (r = -0.255, P = 0.024; r = -0.199, P = 0.027), respectively. The factors necessitating an early keratoplasty were heavy fungal load, deeper penetration of fungus, and possibly insufficient inflammation to combat infection. A granulomatous reaction was noted in the posterior stroma and around the fragmented Descemet's membrane in 23 buttons (13.8%), independent of fungal species. Inflammation was unaffected by elimination of fungus and increasing interval between diagnosis and treatment.
Rapid progression of mycotic keratitis in the early phases is by agent factors such as heavy load and deeper penetration of the fungus, insufficient inflammatory response, and possibly relative ineffectiveness of antifungal agents. Progression in the later phase of mycotic keratitis need not necessarily be agent mediated; it could be either host-modulated, species-related, or drug resistance, thereby suggesting that ideal treatment regimens should include sensitivity-based antifungal therapy aided by in vivo monitoring of fungal filaments.
通过对治疗性角膜移植时获取的人角膜植片进行微生物学评估和组织学研究,评估真菌性角膜炎进展过程中的宿主和病原体因素。
回顾性非对照连续病例系列。
1995年1月至1998年5月间接受治疗性角膜移植的148例经微生物学诊断和治疗的真菌性角膜炎患者的167片角膜植片。
治疗性穿透性角膜移植、微生物学结果回顾、真菌性角膜炎角膜植片的组织病理学和微生物学评估
对植片进行组织学评估,观察形态学改变、炎症细胞的程度和分布、真菌丝的有无及其在角膜植片中的程度和分布。
36例角膜刮片诊断为真菌感染;而131例(78%)真菌在培养物中生长,其中55例(42%)鉴定为曲霉菌,42例(32%)为镰刀菌,22例(17%)为未鉴定的透明真菌,4例(3%)为暗色(未鉴定)真菌,8例(6%)为其他真菌。诊断与角膜移植之间的平均间隔为19(±40)天。在角膜移植标本中,167片中127片(76%)在组织学检查中鉴定出真菌,115片中76片(66%)通过培养技术培养出真菌。角膜植片中鉴定出的真菌种类为镰刀菌30例(39%);曲霉菌25例(33%);未鉴定的透明真菌19例(25%),其他2例(3%)。真菌阳性的角膜植片手术较早(平均15天),而真菌阴性的角膜植片(39天)(P = 0.0005),2周内切除的植片中93%真菌阳性,2个月后为42%。在真菌阳性的植片中,炎症细胞的程度、分布与真菌丝之间分别存在负相关(r = -0.255,P = 0.024;r = -0.199,P = 0.027)。需要早期角膜移植的因素包括真菌负荷重、真菌深层浸润,以及可能对抗感染的炎症反应不足。23片植片(13.8%)后基质和破碎的Descemet膜周围出现肉芽肿反应,与真菌种类无关。炎症不受真菌清除及诊断与治疗间隔时间延长的影响。
真菌性角膜炎早期的快速进展是由病原体因素引起的,如真菌负荷重、深层浸润、炎症反应不足,以及可能抗真菌药物相对无效。真菌性角膜炎后期的进展不一定由病原体介导;可能是宿主调节、菌种相关或耐药性导致的,因此提示理想的治疗方案应包括基于敏感性的抗真菌治疗,并结合真菌丝的体内监测。